Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

N(4)-oleylcytosine arabinoside × Thoracic × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 317 pembrolizumab 300 Pemetrexed 227 Cisplatin 195 Paclitaxel 139 durvalumab 129 Nivolumab 123 osimertinib 96 Docetaxel 93 atezolizumab 92 Specimen Handling 80 Drug Therapy 79 Radiotherapy 70 Magnetic Resonance Spectroscopy 70 Etoposide 64 Gemcitabine 59 Radiosurgery 57 Ipilimumab 47 Bevacizumab 47 tislelizumab 44 130-nm albumin-bound paclitaxel 43 cemiplimab 40 Blood Specimen Collection 35 Biopsy 30 Standard of Care 29 Taxes 28 Platinum 28 Immunotherapy 28 Immune Checkpoint Inhibitors 28 Cetuximab 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05498428 2026-02-13

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡